Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Felix Biotechnology has raised $314K in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Felix Biotechnology's investors include Y Combinator, Pioneer Fund, National Science Foundation, Bossa Invest, Cystic Fibrosis Foundation.
Felix Biotechnology is headquartered in San Francisco, United States.
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Felix Biotechnology is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Felix Biotechnology — Funding & Investors." VCBacked, July 14, 2022, https://www.vcbacked.co/company/felix-biotechnology. Accessed August 13, 2026.
VCBacked. (2022). Felix Biotechnology — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/felix-biotechnology
{{cite web |title=Felix Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/felix-biotechnology |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated